[b]I hate to advocate drugs, alcohol, violence, or insanity to anyone, but they've always worked for me.[/b]
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't remind us.
Good that Nasrat doesn't tweet... huh?
No such luck on your part Doc. A pity he will be around until at least this time next year when Elite will be applying for those SunGen NDAs. LOL!
When insiders sell that is when I will sell.
Good point mrwrn.
Until then accumulate and hold.
There will be a point at which those who bought low will be able to
conservatively capture the money they originally invested.
Some folks already did this on that manipulation run back in February-March of 2014. They were able to get their original investment back and have enough to buy back in at much lower levels, yet put money aside for tax purposes too.
Not looking for a see at anything below $1.60 for minimal share release to recover what I originally invested. Then I let the rest ride ride ride ride let it ride. (BTO)
Much slower ramp? Undoubtedly. Revenues will enough to sustain CFP.
Percocet will be an asset not a detraction.
If Percocet is approved prior to SequestOx launch CFP will happen.
It is amazing what just one drug can do for a company. Specialty drugs that not many companies make due to complexities in manufacturing or development of testing methods can be huge profit makers for pharmaceutical companies.
Although Percocet and Norco do not fall into these categories
SequestOx does due to its PIP ADF technology.
One such drug that is a billion dollar baby in the injectable business is propofol. This milky drug not an easy drug to test or develop.
Big bucks though. Mighty big bucks. Only a few make it.
Only Elite will manufacture SequestOx which as previously mentioned will be the pain management drug of choice.
As also mentioned Percocet will be a nice addition to Elite's drug portfolio. Just with that drug alone the revenues should ramp up nicely. Norco will be another to partner with Percocet in giving Elite revenues that will more than likely triple from where they are today. Very conservative estimates here too.
IB Elite is in the best financial shape of its existence. That includes when Mehta was in charge.
Elite doesn't have to be cash flow positive to start to move off the blocks. CFP will happen soon. Right now they have to spend cash in order to make cash. In order to be the best you have to beat the best. Elite's time is coming.
Nice.
Add the generics currently made and those with filed ANDAS for an additional $60 million annually very conservative estimate.
SunGen's partnered drugs, two of which will be Elite's for an additional $200 million very very conservative estimate.
Close to a billion dollar enterprise with just the ADF SequestOx. That does not count the additional ADF opioids one of which will be the first 24 hour ADF opioid on the market. That alone has to be worth close to a billion in revenue if not more.
This Elite Pharmaceuticals is going to be a playa in the pharmaceutical world. Partners like PuraCap will be a huge help and will benefit both companies moving forward.
$38/share is not out of the question here long term.
Oh crap, I forgot. Elite is on its deathbed.
ROTFLMMFAO!
Totally agree Lasers. Get errr done.
Looking forward to approval on Percocet and Norco.
Just on those two drugs revenues should get a nice boost.
Let's face it Couch... revenues gaining traction, more ANDAS here and more coming..... PuraCap speculation with OxyContin (Oxycotton
as Dems used to put it) and possible Elite involvement... SequestOx
coming....... more opioid ADFs coming....... Elite building its drug portfolio with major hitters..... and yet the detractors still ramble on....
Yeah.... looks like the company is ready to fall any day now. 2 cent shares Johnny.
Just cannot make this stuff up. Impossible.
What was the question? That was my question to Ama. Must have been more than a few questions in that post.
And they will be selective on what they can and will answer. They have to be.
So... out of that whole post you would send her..... what exactly is the question you pose... Donald?
Like anything from that post would be discussed during the open forum CC. It is called company proprietary information. Highly
doubt they would want to indicate to the competition they may have the goods. Guess we will have to wait and see. Right?
Nice catch NASDAQ.
Our pharmaceutical sells to healthcare, hospitals, doctors, and alike.
That was a huge acquisition by Pfizer. Very lucrative too.
Depending on the number of manufacturers involved injectable narcotics can be a big money maker if the product being sold is in short supply. Or if the product is found to need special testing.
Ketorolac requires special testing as does heparin. Big money if one has just those two drugs and there are not to many players manufacturing them.
Fentanyl, hydromorphone, morphine (with duramorh and infumorph), meperidine(Demerol), phenobarbital, the antipsychotic prochlorperizine, neostigmine....... and others all make up some of what injectable companies may carry.
Digoxin, doxapram, diphenhydramine, dexamethasone, ondansetron, dicyclomine, phenytoin, promethazine, cardene are some other injectable products that can really add to the bottom line depending on market need and saturation.
I think Elite has something much better being an oral form.
Pills and capsules will always be a huge mover in their own right.
Looking forward to Percocet, Norco, and other generics on the back burner. the first two mentioned should do very well revenue wise.
Interesting that Pfizer bought Hospira injectable. That Pfizer will be going the injectable route.
Already in injectable pharmaceuticals myself. Interesting take
Lasers.
If Pfizer does relieve itself of oral doses that would open the door even more for Elite. Just my opinion.
Purdue could have possibly had Elite's technology...... good for us that they screwed up.
I've been hearing the bit about Elite never getting patents on this or that. That Elite's technology was run again tech. All of this since 2011.
As we can all see Elite's patents hold up strong. Elite's technology is solid and now Elite is about to embark on a transition
to a real pharmaceutical with revenue making generics and the first ever solid opioid ADF platform. No other pharmaceutical can even come close. Even the big boys realize this.
It is coming.
No more golden handshakes? LOL LOL!
ERs will gladly prescribe this ADF. No more having to keep strict
guidance on pain relief for the patients who need it. Docs will benefit too as restrictions may be relaxed or in some cases lifted.
It is going to be a good thing to help squelch the prescription opioid abuse problem while helping those who need prescription opioids for pain management.
Josh Shapiro Attorney General of Pennsylvania very much on the
prescription opioid abuse ban wagon.
It is coming.
What the hell is a noob?
Second question:
What the hell is a noob?
Started out above $0.17 this morning to drop to $0.16 at 10am.
Now share price is headed back toward $0.17. 1 day chart says it all. This is a pattern we have seen with Elite before. The mid-day drop followed by the afternoon buying.
Classic........
Just a Percocet approval will do for now. that will get things started in the right direction.
Don... I would walk a mile for 17 cent support any day.
Tax loss selling is over. People starting to load up.
NASDAQ the $25 million you mentioned from Percocet alone is a very conservative number which I like very much.
It only accounts for about 3.6% of the total market US. I like the wiggle room to add an additional 3-4% on top of that once they ramp up. So $42-$50 million possible from Percocet alone if they capture
6-7% of the current US market. With PuraCap as a partner the figure could be much higher if they take it over seas.
Elite is and continues to be an interesting company. It will be that way for some years to come IMO.
Once Elite establishes itself with a variety of generics and opioid ADFs the potential buyout figure becomes... shall we say... more interesting.
NH and company are moving in the right direction NASDAQ.
Love the way you think buddy.
That is $100 million without the two generics being worked on
by Elite in collaboration with SunGen. On top of that there are still IR and ER opioid ADFs to be filed.
And lets not forget the latest ANDA, hydrocodone-acetaminophen.
If they even tap 7-8% of the current market for both Percocet and that they will be in fine shape IMO.
We will all have to have patience. Official minutes of the meeting will be available when they are officially available and not before.
Meanwhile buy more Elite.
Amazing how a simple "labeling issue" when Tmax issue was originally brought up to the FDA by NH turned a 180 in the FDAs
eyes to a Tmax issue. Total BS.
FDA making it up as they go. Like usual.
Correct again.
Correct!
Classic push down to accumulate more at cheaper prices.
Hope this continues so that I may be able to increase my positon.
Whatever they want to do......